Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging

PURPOSE: Carbohydrate antigen (CA) 19-9 has been established as the main serum marker for patients with intrahepatic cholangiocarcinoma (ICC). The aim of this study was to compare the prognostic value of CA 19-9 changes versus response determined by imaging in patients with ICC undergoing chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Hahn, Felix, Müller, Lukas, Jungmann, Florian, Mähringer-Kunz, Aline, Tanyildizi, Yasemin, Düber, Christoph, Galle, Peter R., Weinmann, Arndt, Kloeckner, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256028/
https://www.ncbi.nlm.nih.gov/pubmed/32232655
http://dx.doi.org/10.1007/s00432-020-03200-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256028/
https://www.ncbi.nlm.nih.gov/pubmed/32232655
http://dx.doi.org/10.1007/s00432-020-03200-2

Ejemplares similares